Literature DB >> 8934648

IL-3 receptor expression, regulation and function in cells of the vasculature.

E I Korpelainen1, J R Gamble, M A Vadas, A F Lopez.   

Abstract

IL-3 is a haemopoietic growth factor which stimulates the production and functional activity of various blood cell types. Recent evidence suggests that the target cell population of IL-3 is not restricted to haemopoietic cells as previously thought, but vascular cells such as endothelial cells also express receptors for and respond to this cytokine. Interestingly, IL-3 was found to regulate endothelial responses related to inflammation, immunity and haemopoiesis. These findings, summarized in this review, offer new insight into the physiological function of IL-3 and may also be of clinical importance, as IL-3 is used in bone marrow reconstitution following cancer therapy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8934648     DOI: 10.1038/icb.1996.1

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  21 in total

1.  Early up-regulation of Th2 cytokines and late surge of Th1 cytokines in an atopic dermatitis model.

Authors:  L Chen; O Martinez; L Overbergh; C Mathieu; B S Prabhakar; L S Chan
Journal:  Clin Exp Immunol       Date:  2004-12       Impact factor: 4.330

2.  Programmed assembly of 3-dimensional microtissues with defined cellular connectivity.

Authors:  Zev J Gartner; Carolyn R Bertozzi
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-09       Impact factor: 11.205

3.  CD123-Engager T Cells as a Novel Immunotherapeutic for Acute Myeloid Leukemia.

Authors:  Challice L Bonifant; Arpad Szoor; David Torres; Nicholos Joseph; Mireya Paulina Velasquez; Kota Iwahori; Amos Gaikwad; Phuong Nguyen; Caroline Arber; Xiao-Tong Song; Michele Redell; Stephen Gottschalk
Journal:  Mol Ther       Date:  2016-06-06       Impact factor: 11.454

4.  Antileukemia Efficacy and Mechanisms of Action of SL-101, a Novel Anti-CD123 Antibody Conjugate, in Acute Myeloid Leukemia.

Authors:  Lina Han; Jeffrey L Jorgensen; Chris Brooks; Ce Shi; Qi Zhang; Graciela M Nogueras González; Antonio Cavazos; Rongqing Pan; Hong Mu; Sa A Wang; Jin Zhou; Gheath Ai-Atrash; Stefan O Ciurea; Mike Rettig; John F DiPersio; Jorge Cortes; Xuelin Huang; Hagop M Kantarjian; Michael Andreeff; Farhad Ravandi; Marina Konopleva
Journal:  Clin Cancer Res       Date:  2017-01-17       Impact factor: 12.531

5.  T-cell Activity against AML Improved by Dual-Targeted T Cells Stimulated through T-cell and IL7 Receptors.

Authors:  Eric Krawczyk; Sergey N Zolov; Kevin Huang; Challice L Bonifant
Journal:  Cancer Immunol Res       Date:  2019-02-19       Impact factor: 11.151

6.  Cutting edge: basophils are transiently recruited into the draining lymph nodes during helminth infection via IL-3, but infection-induced Th2 immunity can develop without basophil lymph node recruitment or IL-3.

Authors:  Sohee Kim; Melanie Prout; Hayley Ramshaw; Angel F Lopez; Graham LeGros; Booki Min
Journal:  J Immunol       Date:  2009-12-28       Impact factor: 5.422

7.  Anti-CTLA-4 synergizes with dendritic cell-targeted vaccine to promote IL-3-dependent CD4+ effector T cell infiltration into murine pancreatic tumors.

Authors:  Neeha Zaidi; Sergio A Quezada; Janelle M Y Kuroiwa; Li Zhang; Elizabeth M Jaffee; Ralph M Steinman; Bei Wang
Journal:  Ann N Y Acad Sci       Date:  2019-04-04       Impact factor: 6.499

8.  Enumeration and phenotypical analysis of distinct dendritic cell subsets in psoriatic arthritis and rheumatoid arthritis.

Authors:  Sarah L Jongbloed; M Cristina Lebre; Alasdair R Fraser; J Alastair Gracie; Roger D Sturrock; Paul P Tak; Iain B McInnes
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

9.  {beta}1 Integrin and IL-3R coordinately regulate STAT5 activation and anchorage-dependent proliferation.

Authors:  Paola Defilippi; Arturo Rosso; Patrizia Dentelli; Cristina Calvi; Giovanni Garbarino; Guido Tarone; Luigi Pegoraro; Maria Felice Brizzi
Journal:  J Cell Biol       Date:  2005-03-28       Impact factor: 10.539

10.  Pro-oncogenic cytokines and growth factors are differentially expressed in the post-surgical wound fluid from malignant compared to benign breast lesions.

Authors:  Amanda Valeta-Magara; Raheleh Hatami; Deborah Axelrod; Daniel F Roses; Amber Guth; Silvia C Formenti; Robert J Schneider
Journal:  Springerplus       Date:  2015-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.